Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Mar;109(Suppl 1):5–20. doi: 10.1289/ehp.01109s15

Cross-species and interassay comparisons of phytoestrogen action.

P L Whitten 1, H B Patisaul 1
PMCID: PMC1240538  PMID: 11250801

Abstract

This paper compiles animal and human data on the biologic effects and exposure levels of phytoestrogens in order to identify areas of research in which direct species comparisons can be made. In vitro and in vivo assays of phytoestrogen action and potency are reviewed and compared to actions, dose-response relationships, and estimates of exposure in human subjects. Binding studies show that the isoflavonoid phytoestrogens are high-affinity ligands for estrogen receptors (ERs), especially ER beta, but have lower potency in whole-cell assays, perhaps because of interactions with binding proteins. Many other enzymatic actions require concentrations higher than those normally seen in plasma. In vivo data show that phytoestrogens have a wide range of biologic effects at doses and plasma concentrations seen with normal human diets. Significant in vivoresponses have been observed in animal and human tests for bone, breast, ovary, pituitary, vasculature, prostate, and serum lipids. The doses reported to be biologically active in humans (0.4--10 mg/kg body weight/day) are lower than the doses generally reported to be active in rodents (10--100 mg/kg body weight/day), although some studies have reported rodent responses at lower doses. However, available estimates of bioavailability and peak plasma levels in rodents and humans are more similar. Steroidogenesis and the hypothalamic-pituitary-gonadal axis appear to be important loci of phytoestrogen actions, but these inferences must be tentative because good dose-response data are not available for many end points. The similarity of reported proliferative and antiproliferative doses illustrates the need for fuller examination of dose-response relationships and multiple end points in assessing phytoestrogen actions.

Full Text

The Full Text of this article is available as a PDF (725.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami S., Bufalino L., Cervetti R., Di Marco C., Di Munno O., Fantasia L., Isaia G. C., Serni U., Vecchiet L., Passeri M. Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years. Osteoporos Int. 1997;7(2):119–125. doi: 10.1007/BF01623686. [DOI] [PubMed] [Google Scholar]
  2. Adams N. R. Detection of the effects of phytoestrogens on sheep and cattle. J Anim Sci. 1995 May;73(5):1509–1515. doi: 10.2527/1995.7351509x. [DOI] [PubMed] [Google Scholar]
  3. Adlercreutz C. H., Goldin B. R., Gorbach S. L., Höckerstedt K. A., Watanabe S., Hämäläinen E. K., Markkanen M. H., Mäkelä T. H., Wähälä K. T., Adlercreutz T. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995 Mar;125(3 Suppl):757S–770S. doi: 10.1093/jn/125.3_Suppl.757S. [DOI] [PubMed] [Google Scholar]
  4. Adlercreutz H., Bannwart C., Wähälä K., Mäkelä T., Brunow G., Hase T., Arosemena P. J., Kellis J. T., Jr, Vickery L. E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol. 1993 Feb;44(2):147–153. doi: 10.1016/0960-0760(93)90022-o. [DOI] [PubMed] [Google Scholar]
  5. Adlercreutz H., Fotsis T., Lampe J., Wähälä K., Mäkelä T., Brunow G., Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest Suppl. 1993;215:5–18. doi: 10.3109/00365519309090693. [DOI] [PubMed] [Google Scholar]
  6. Adlercreutz H., Fotsis T., Watanabe S., Lampe J., Wähälä K., Mäkelä T., Hase T. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev. 1994;18(4):259–271. [PubMed] [Google Scholar]
  7. Adlercreutz H., Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997 Apr;29(2):95–120. doi: 10.3109/07853899709113696. [DOI] [PubMed] [Google Scholar]
  8. Adlercreutz H., Yamada T., Wähälä K., Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):737–743. doi: 10.1016/s0002-9378(99)70281-4. [DOI] [PubMed] [Google Scholar]
  9. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Rémésy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol. 1997 Jun 1;53(11):1649–1657. doi: 10.1016/s0006-2952(97)82453-7. [DOI] [PubMed] [Google Scholar]
  10. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
  11. Albanese C. V., Cudd A., Argentino L., Zambonin-Zallone A., MacIntyre I. Ipriflavone directly inhibits osteoclastic activity. Biochem Biophys Res Commun. 1994 Mar 15;199(2):930–936. doi: 10.1006/bbrc.1994.1318. [DOI] [PubMed] [Google Scholar]
  12. Albertazzi P., Pansini F., Bonaccorsi G., Zanotti L., Forini E., De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol. 1998 Jan;91(1):6–11. doi: 10.1016/s0029-7844(97)00597-8. [DOI] [PubMed] [Google Scholar]
  13. Anderson J. J., Ambrose W. W., Garner S. C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med. 1998 Mar;217(3):345–350. doi: 10.3181/00379727-217-44243. [DOI] [PubMed] [Google Scholar]
  14. Anthony M. S., Clarkson T. B., Hughes C. L., Jr, Morgan T. M., Burke G. L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996 Jan;126(1):43–50. doi: 10.1093/jn/126.1.43. [DOI] [PubMed] [Google Scholar]
  15. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H., Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000 Mar;10(2):127–135. doi: 10.2188/jea.10.127. [DOI] [PubMed] [Google Scholar]
  16. Arnold S. F., Collins B. M., Robinson M. K., Guillette L. J., Jr, McLachlan J. A. Differential interaction of natural and synthetic estrogens with extracellular binding proteins in a yeast estrogen screen. Steroids. 1996 Nov;61(11):642–646. doi: 10.1016/s0039-128x(96)00183-3. [DOI] [PubMed] [Google Scholar]
  17. Arts J., Kuiper G. G., Janssen J. M., Gustafsson J. A., Löwik C. W., Pols H. A., van Leeuwen J. P. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology. 1997 Nov;138(11):5067–5070. doi: 10.1210/endo.138.11.5652. [DOI] [PubMed] [Google Scholar]
  18. Awoniyi C. A., Roberts D., Veeramachaneni D. N., Hurst B. S., Tucker K. E., Schlaff W. D. Reproductive sequelae in female rats after in utero and neonatal exposure to the phytoestrogen genistein. Fertil Steril. 1998 Sep;70(3):440–447. doi: 10.1016/s0015-0282(98)00185-x. [DOI] [PubMed] [Google Scholar]
  19. Axelson M., Sjövall J., Gustafsson B. E., Setchell K. D. Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982 Aug 12;298(5875):659–660. doi: 10.1038/298659a0. [DOI] [PubMed] [Google Scholar]
  20. Baird D. D., Umbach D. M., Lansdell L., Hughes C. L., Setchell K. D., Weinberg C. R., Haney A. F., Wilcox A. J., Mclachlan J. A. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 1995 May;80(5):1685–1690. doi: 10.1210/jcem.80.5.7745019. [DOI] [PubMed] [Google Scholar]
  21. Baker M. E., Medlock K. L., Sheehan D. M. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proc Soc Exp Biol Med. 1998 Mar;217(3):317–321. doi: 10.3181/00379727-217-44238. [DOI] [PubMed] [Google Scholar]
  22. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol. 1998 Jul;54(1):105–112. doi: 10.1124/mol.54.1.105. [DOI] [PubMed] [Google Scholar]
  23. Barnes S., Peterson G., Grubbs C., Setchell K. Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol. 1994;354:135–147. doi: 10.1007/978-1-4899-0939-8_10. [DOI] [PubMed] [Google Scholar]
  24. Barnes S., Peterson T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med. 1995 Jan;208(1):103–108. doi: 10.3181/00379727-208-43840. [DOI] [PubMed] [Google Scholar]
  25. Barnes S., Sfakianos J., Coward L., Kirk M. Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol. 1996;401:87–100. doi: 10.1007/978-1-4613-0399-2_7. [DOI] [PubMed] [Google Scholar]
  26. Benvenuti S., Petilli M., Frediani U., Tanini A., Fiorelli G., Bianchi S., Bernabei P. A., Albanese C., Brandi M. L. Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1084–1089. doi: 10.1006/bbrc.1994.1816. [DOI] [PubMed] [Google Scholar]
  27. Boutin J. A. Tyrosine protein kinase inhibition and cancer. Int J Biochem. 1994 Oct-Nov;26(10-11):1203–1226. doi: 10.1016/0020-711x(94)90091-4. [DOI] [PubMed] [Google Scholar]
  28. Brown N. M., Wang J., Cotroneo M. S., Zhao Y. X., Lamartiniere C. A. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol. 1998 Sep 25;144(1-2):149–165. doi: 10.1016/s0303-7207(98)00106-3. [DOI] [PubMed] [Google Scholar]
  29. Burroughs C. D. Long-term reproductive tract alterations in female mice treated neonatally with coumestrol. Proc Soc Exp Biol Med. 1995 Jan;208(1):78–81. doi: 10.3181/00379727-208-43835. [DOI] [PubMed] [Google Scholar]
  30. Campbell D. R., Kurzer M. S. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol. 1993 Sep;46(3):381–388. doi: 10.1016/0960-0760(93)90228-o. [DOI] [PubMed] [Google Scholar]
  31. Carter B. S., Carter H. B., Isaacs J. T. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate. 1990;16(3):187–197. doi: 10.1002/pros.2990160302. [DOI] [PubMed] [Google Scholar]
  32. Casanova M., You L., Gaido K. W., Archibeque-Engle S., Janszen D. B., Heck H. A. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci. 1999 Oct;51(2):236–244. doi: 10.1093/toxsci/51.2.236. [DOI] [PubMed] [Google Scholar]
  33. Cassidy A., Bingham S., Setchell K. D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994 Sep;60(3):333–340. doi: 10.1093/ajcn/60.3.333. [DOI] [PubMed] [Google Scholar]
  34. Castro A. F., Altenberg G. A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol. 1997 Jan 10;53(1):89–93. doi: 10.1016/s0006-2952(96)00657-0. [DOI] [PubMed] [Google Scholar]
  35. Cecchini M. G., Fleisch H., Mühibauer R. C. Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcif Tissue Int. 1997;61 (Suppl 1):S9–11. doi: 10.1007/s002239900377. [DOI] [PubMed] [Google Scholar]
  36. Chang H. C., Churchwell M. I., Delclos K. B., Newbold R. R., Doerge D. R. Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr. 2000 Aug;130(8):1963–1970. doi: 10.1093/jn/130.8.1963. [DOI] [PubMed] [Google Scholar]
  37. Charland SL, Hui JW, Torosian MH. The effects of a soybean extract on tumor growth and metastasis. Int J Mol Med. 1998 Aug;2(2):225–228. [PubMed] [Google Scholar]
  38. Chen S., Kao Y. C., Laughton C. A. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase. J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):107–115. [PubMed] [Google Scholar]
  39. Clarke R., Hilakivi-Clarke L., Cho E., James M. R., Leonessa F. Estrogens, phytoestrogens, and breast cancer. Adv Exp Med Biol. 1996;401:63–85. doi: 10.1007/978-1-4613-0399-2_6. [DOI] [PubMed] [Google Scholar]
  40. Cline J. M., Paschold J. C., Anthony M. S., Obasanjo I. O., Adams M. R. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril. 1996 May;65(5):1031–1035. [PubMed] [Google Scholar]
  41. Coldham N. G., Dave M., Sivapathasundaram S., McDonnell D. P., Connor C., Sauer M. J. Evaluation of a recombinant yeast cell estrogen screening assay. Environ Health Perspect. 1997 Jul;105(7):734–742. doi: 10.1289/ehp.97105734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Coldham N. G., Sauer M. J. Pharmacokinetics of [(14)C]Genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol Appl Pharmacol. 2000 Apr 15;164(2):206–215. doi: 10.1006/taap.2000.8902. [DOI] [PubMed] [Google Scholar]
  43. Cole G. M., Galasko D., Shapiro I. P., Saitoh T. Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun. 1990 Jul 16;170(1):288–295. doi: 10.1016/0006-291x(90)91272-t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Collier F. M., Huang W. H., Holloway W. R., Hodge J. M., Gillespie M. T., Daniels L. L., Zheng M. H., Nicholson G. C. Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology. 1998 Mar;139(3):1258–1267. doi: 10.1210/endo.139.3.5825. [DOI] [PubMed] [Google Scholar]
  45. Collins B. M., McLachlan J. A., Arnold S. F. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids. 1997 Apr;62(4):365–372. doi: 10.1016/s0039-128x(96)00246-2. [DOI] [PubMed] [Google Scholar]
  46. Constantinou A. I., Mehta R. G., Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 1996 Nov-Dec;16(6A):3293–3298. [PubMed] [Google Scholar]
  47. Constantinou A., Kiguchi K., Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 1990 May 1;50(9):2618–2624. [PubMed] [Google Scholar]
  48. Couse J. F., Lindzey J., Grandien K., Gustafsson J. A., Korach K. S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 1997 Nov;138(11):4613–4621. doi: 10.1210/endo.138.11.5496. [DOI] [PubMed] [Google Scholar]
  49. Crain D. A., Noriega N., Vonier P. M., Arnold S. F., McLachlan J. A., Guillette L. J., Jr Cellular bioavailability of natural hormones and environmental contaminants as a function of serum and cytosolic binding factors. Toxicol Ind Health. 1998 Jan-Apr;14(1-2):261–273. doi: 10.1177/074823379801400116. [DOI] [PubMed] [Google Scholar]
  50. Crisp T. M., Clegg E. D., Cooper R. L., Wood W. P., Anderson D. G., Baetcke K. P., Hoffmann J. L., Morrow M. S., Rodier D. J., Schaeffer J. E. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect. 1998 Feb;106 (Suppl 1):11–56. doi: 10.1289/ehp.98106s111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Damassa D. A., Cates J. M. Sex hormone-binding globulin and male sexual development. Neurosci Biobehav Rev. 1995 Summer;19(2):165–175. doi: 10.1016/0149-7634(95)00014-6. [DOI] [PubMed] [Google Scholar]
  52. Dees C., Foster J. S., Ahamed S., Wimalasena J. Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ Health Perspect. 1997 Apr;105 (Suppl 3):633–636. doi: 10.1289/ehp.97105s3633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Diel P., Schulz T., Smolnikar K., Strunck E., Vollmer G., Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol. 2000 May;73(1-2):1–10. doi: 10.1016/s0960-0760(00)00051-0. [DOI] [PubMed] [Google Scholar]
  54. Dodge J. A., Glasebrook A. L., Magee D. E., Phillips D. L., Sato M., Short L. L., Bryant H. U. Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. J Steroid Biochem Mol Biol. 1996 Oct;59(2):155–161. doi: 10.1016/s0960-0760(96)00104-5. [DOI] [PubMed] [Google Scholar]
  55. Draper C. R., Edel M. J., Dick I. M., Randall A. G., Martin G. B., Prince R. L. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr. 1997 Sep;127(9):1795–1799. doi: 10.1093/jn/127.9.1795. [DOI] [PubMed] [Google Scholar]
  56. Duncan A. M., Merz B. E., Xu X., Nagel T. C., Phipps W. R., Kurzer M. S. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999 Jan;84(1):192–197. doi: 10.1210/jcem.84.1.5387. [DOI] [PubMed] [Google Scholar]
  57. Déchaud H., Ravard C., Claustrat F., de la Perrière A. B., Pugeat M. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids. 1999 May;64(5):328–334. doi: 10.1016/s0039-128x(98)00114-7. [DOI] [PubMed] [Google Scholar]
  58. Evans B. A., Griffiths K., Morton M. S. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 1995 Nov;147(2):295–302. doi: 10.1677/joe.0.1470295. [DOI] [PubMed] [Google Scholar]
  59. Faber K. A., Hughes C. L., Jr The effect of neonatal exposure to diethylstilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Biol Reprod. 1991 Oct;45(4):649–653. doi: 10.1095/biolreprod45.4.649. [DOI] [PubMed] [Google Scholar]
  60. Fitzpatrick S. L., Berrodin T. J., Jenkins S. F., Sindoni D. M., Deecher D. C., Frail D. E. Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line. Endocrinology. 1999 Sep;140(9):3928–3937. doi: 10.1210/endo.140.9.7006. [DOI] [PubMed] [Google Scholar]
  61. Foth D., Cline J. M. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1413S–1417S. doi: 10.1093/ajcn/68.6.1413S. [DOI] [PubMed] [Google Scholar]
  62. Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr. 1995 Mar;125(3 Suppl):790S–797S. doi: 10.1093/jn/125.suppl_3.790S. [DOI] [PubMed] [Google Scholar]
  63. Franke A. A., Custer L. J. Daidzein and genistein concentrations in human milk after soy consumption. Clin Chem. 1996 Jun;42(6 Pt 1):955–964. [PubMed] [Google Scholar]
  64. Franke A. A., Custer L. J., Wang W., Shi C. Y. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med. 1998 Mar;217(3):263–273. doi: 10.3181/00379727-217-44231. [DOI] [PubMed] [Google Scholar]
  65. Gamache P. H., Acworth I. N. Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med. 1998 Mar;217(3):274–280. doi: 10.3181/00379727-217-44232. [DOI] [PubMed] [Google Scholar]
  66. Gambacciani M., Spinetti A., Piaggesi L., Cappagli B., Taponeco F., Manetti P., Weiss C., Teti G. C., La Commare P., Facchini V. Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists. Bone Miner. 1994 Jul;26(1):19–26. doi: 10.1016/s0169-6009(08)80159-6. [DOI] [PubMed] [Google Scholar]
  67. Garreau B., Vallette G., Adlercreutz H., Wähälä K., Mäkelä T., Benassayag C., Nunez E. A. Phytoestrogens: new ligands for rat and human alpha-fetoprotein. Biochim Biophys Acta. 1991 Sep 24;1094(3):339–345. doi: 10.1016/0167-4889(91)90095-f. [DOI] [PubMed] [Google Scholar]
  68. Geller J., Sionit L., Partido C., Li L., Tan X., Youngkin T., Nachtsheim D., Hoffman R. M. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate. 1998 Feb 1;34(2):75–79. doi: 10.1002/(sici)1097-0045(19980201)34:2<75::aid-pros1>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  69. Germain P., Egloff M., Kiefer H., Metezeau P., Habrioux G. Use of confocal microscopy to localize the SHBG interaction with human breast cancer cell lines--a comparison with serum albumin interaction. Cell Mol Biol (Noisy-le-grand) 1997 Jun;43(4):501–508. [PubMed] [Google Scholar]
  70. Germain P., Metezeau P., Hellio R., Habrioux G. Internalization and biological effects of serum albumin in the breast cancer MCF-7 and MDA-MB 231 cells. Cell Mol Biol (Noisy-le-grand) 1995 Dec;41(8):1119–1129. [PubMed] [Google Scholar]
  71. Gooderham M. H., Adlercreutz H., Ojala S. T., Wähälä K., Holub B. J. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr. 1996 Aug;126(8):2000–2006. doi: 10.1093/jn/126.8.2000. [DOI] [PubMed] [Google Scholar]
  72. Goodman M. T., Wilkens L. R., Hankin J. H., Lyu L. C., Wu A. H., Kolonel L. N. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol. 1997 Aug 15;146(4):294–306. doi: 10.1093/oxfordjournals.aje.a009270. [DOI] [PubMed] [Google Scholar]
  73. Hess R. A., Gist D. H., Bunick D., Lubahn D. B., Farrell A., Bahr J., Cooke P. S., Greene G. L. Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl. 1997 Nov-Dec;18(6):602–611. [PubMed] [Google Scholar]
  74. Hidy P. H., Baldwin R. S., Greasham R. L., Keith C. L., McMullen J. R. Zearalenone and some derivatives: production and biological activities. Adv Appl Microbiol. 1977;22:59–82. doi: 10.1016/s0065-2164(08)70160-6. [DOI] [PubMed] [Google Scholar]
  75. Hobbs C. J., Jones R. E., Plymate S. R. The effects of sex hormone binding globulin (SHBG) on testosterone transport into the cerebrospinal fluid. J Steroid Biochem Mol Biol. 1992 Jul;42(6):629–635. doi: 10.1016/0960-0760(92)90455-r. [DOI] [PubMed] [Google Scholar]
  76. Hobson W., Bailey J., Fuller G. B. Hormone effects of zearalenone in nonhuman primates. J Toxicol Environ Health. 1977 Sep;3(1-2):43–57. doi: 10.1080/15287397709529548. [DOI] [PubMed] [Google Scholar]
  77. Hodgson J. M., Puddey I. B., Beilin L. J., Mori T. A., Croft K. D. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr. 1998 Apr;128(4):728–732. doi: 10.1093/jn/128.4.728. [DOI] [PubMed] [Google Scholar]
  78. Honoré E. K., Williams J. K., Anthony M. S., Clarkson T. B. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997 Jan;67(1):148–154. doi: 10.1016/s0015-0282(97)81872-9. [DOI] [PubMed] [Google Scholar]
  79. Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998 Sep 1;58(17):3833–3838. [PubMed] [Google Scholar]
  80. Hughes C. L., Jr, Chakinala M. M., Reece S. G., Miller R. N., Schomberg D. W., Jr, Basham K. B. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: Part 2. Reprod Toxicol. 1991;5(2):133–137. doi: 10.1016/0890-6238(91)90041-d. [DOI] [PubMed] [Google Scholar]
  81. Hughes C. L., Jr Effects of phytoestrogens on GnRH-induced luteinizing hormone secretion in ovariectomized rats. Reprod Toxicol. 1987 1988;1(3):179–181. doi: 10.1016/s0890-6238(87)80030-8. [DOI] [PubMed] [Google Scholar]
  82. Hughes C. L., Jr, Kaldas R. S., Weisinger A. S., McCants C. E., Basham K. B. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: Part 1. Reprod Toxicol. 1991;5(2):127–132. doi: 10.1016/0890-6238(91)90040-m. [DOI] [PubMed] [Google Scholar]
  83. Hutchins A. M., Slavin J. L., Lampe J. W. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc. 1995 May;95(5):545–551. doi: 10.1016/S0002-8223(95)00149-2. [DOI] [PubMed] [Google Scholar]
  84. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997 Oct 4;350(9083):990–994. doi: 10.1016/S0140-6736(97)01339-1. [DOI] [PubMed] [Google Scholar]
  85. Kao Y. C., Zhou C., Sherman M., Laughton C. A., Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect. 1998 Feb;106(2):85–92. doi: 10.1289/ehp.9810685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Kaufman P. B., Duke J. A., Brielmann H., Boik J., Hoyt J. E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Complement Med. 1997 Spring;3(1):7–12. doi: 10.1089/acm.1997.3.7. [DOI] [PubMed] [Google Scholar]
  87. Kellis J. T., Jr, Vickery L. E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 1984 Sep 7;225(4666):1032–1034. doi: 10.1126/science.6474163. [DOI] [PubMed] [Google Scholar]
  88. Kelly G. E., Joannou G. E., Reeder A. Y., Nelson C., Waring M. A. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med. 1995 Jan;208(1):40–43. doi: 10.3181/00379727-208-43829. [DOI] [PubMed] [Google Scholar]
  89. Kelly G. E., Nelson C., Waring M. A., Joannou G. E., Reeder A. Y. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta. 1993 Dec 31;223(1-2):9–22. doi: 10.1016/0009-8981(93)90058-c. [DOI] [PubMed] [Google Scholar]
  90. Kim S. H., Lee J. S., Lee M. G. Determination of a isoflavone derivative, ipriflavone, and its metabolites, M1 and M5, in rat plasma, urine, and tissue homogenate by high-performance liquid chromatography. Res Commun Mol Pathol Pharmacol. 1997 Dec;98(3):313–324. [PubMed] [Google Scholar]
  91. King R. A., Broadbent J. L., Head R. J. Absorption and excretion of the soy isoflavone genistein in rats. J Nutr. 1996 Jan;126(1):176–182. doi: 10.1093/jn/126.1.176. [DOI] [PubMed] [Google Scholar]
  92. King R. A., Bursill D. B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998 May;67(5):867–872. doi: 10.1093/ajcn/67.5.867. [DOI] [PubMed] [Google Scholar]
  93. King R. A., Bursill D. B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998 May;67(5):867–872. doi: 10.1093/ajcn/67.5.867. [DOI] [PubMed] [Google Scholar]
  94. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
  95. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
  96. Kurzer M. S., Xu X. Dietary phytoestrogens. Annu Rev Nutr. 1997;17:353–381. doi: 10.1146/annurev.nutr.17.1.353. [DOI] [PubMed] [Google Scholar]
  97. Lamartiniere C. A., Moore J. B., Brown N. M., Thompson R., Hardin M. J., Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 1995 Nov;16(11):2833–2840. doi: 10.1093/carcin/16.11.2833. [DOI] [PubMed] [Google Scholar]
  98. Lamartiniere C. A., Murrill W. B., Manzolillo P. A., Zhang J. X., Barnes S., Zhang X., Wei H., Brown N. M. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med. 1998 Mar;217(3):358–364. doi: 10.3181/00379727-217-44245. [DOI] [PubMed] [Google Scholar]
  99. Lapcík O., Hill M., Hampl R., Wähälä K., Adlercreutz H. Identification of isoflavonoids in beer. Steroids. 1998 Jan;63(1):14–20. doi: 10.1016/s0039-128x(97)00104-9. [DOI] [PubMed] [Google Scholar]
  100. Leavitt W. W. Relative effectiveness of estradiol and coumestrol on the reversal of castration changes in the anterior pituitary of mice. Endocrinology. 1965 Aug;77(2):247–254. doi: 10.1210/endo-77-2-247. [DOI] [PubMed] [Google Scholar]
  101. Leavitt W. W., Wright P. A. The plant estrogen, coumestrol, as an agent affecting hypophysial gonadotropic function. J Exp Zool. 1965 Dec;160(3):319–327. doi: 10.1002/jez.1401600309. [DOI] [PubMed] [Google Scholar]
  102. Leopold A. S., Erwin M., Oh J., Browning B. Phytoestrogens: adverse effects on reproduction in California quail. Science. 1976 Jan 9;191(4222):98–100. doi: 10.1126/science.1246602. [DOI] [PubMed] [Google Scholar]
  103. Lephart E. D., Thompson J. M., Setchell K. D., Adlercreutz H., Weber K. S. Phytoestrogens decrease brain calcium-binding proteins but do not alter hypothalamic androgen metabolizing enzymes in adult male rats. Brain Res. 2000 Mar 17;859(1):123–131. doi: 10.1016/s0006-8993(00)01968-5. [DOI] [PubMed] [Google Scholar]
  104. Levy J. R., Faber K. A., Ayyash L., Hughes C. L., Jr The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med. 1995 Jan;208(1):60–66. doi: 10.3181/00379727-208-43832. [DOI] [PubMed] [Google Scholar]
  105. Lopez J., Ogren L., Verjan R., Talamantes F. Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology. 1988 Aug;38(2):129–134. doi: 10.1002/tera.1420380205. [DOI] [PubMed] [Google Scholar]
  106. Lu L. J., Anderson K. E., Grady J. J., Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):63–70. [PubMed] [Google Scholar]
  107. Lu L. J., Grady J. J., Marshall M. V., Ramanujam V. M., Anderson K. E. Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. Nutr Cancer. 1995;24(3):311–323. doi: 10.1080/01635589509514420. [DOI] [PubMed] [Google Scholar]
  108. Lundh T. Metabolism of estrogenic isoflavones in domestic animals. Proc Soc Exp Biol Med. 1995 Jan;208(1):33–39. doi: 10.3181/00379727-208-43828. [DOI] [PubMed] [Google Scholar]
  109. Markiewicz L., Garey J., Adlercreutz H., Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol. 1993 May;45(5):399–405. doi: 10.1016/0960-0760(93)90009-l. [DOI] [PubMed] [Google Scholar]
  110. Martin M. E., Haourigui M., Pelissero C., Benassayag C., Nunez E. A. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci. 1996;58(5):429–436. doi: 10.1016/0024-3205(95)02308-9. [DOI] [PubMed] [Google Scholar]
  111. Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978 Nov;103(5):1860–1867. doi: 10.1210/endo-103-5-1860. [DOI] [PubMed] [Google Scholar]
  112. Mayr U., Butsch A., Schneider S. Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology. 1992 Sep;74(2-3):135–149. doi: 10.1016/0300-483x(92)90134-z. [DOI] [PubMed] [Google Scholar]
  113. Mazur W. M., Wähälä K., Rasku S., Salakka A., Hase T., Adlercreutz H. Lignan and isoflavonoid concentrations in tea and coffee. Br J Nutr. 1998 Jan;79(1):37–45. doi: 10.1079/bjn19980007. [DOI] [PubMed] [Google Scholar]
  114. McMichael-Phillips D. F., Harding C., Morton M., Roberts S. A., Howell A., Potten C. S., Bundred N. J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1431S–1435S. doi: 10.1093/ajcn/68.6.1431S. [DOI] [PubMed] [Google Scholar]
  115. Medlock K. L., Branham W. S., Sheehan D. M. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med. 1995 Jan;208(1):67–71. doi: 10.3181/00379727-208-43833. [DOI] [PubMed] [Google Scholar]
  116. Meyer S., Brumm C., Stegner H. E., Sinnecker G. H. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency? Exp Clin Endocrinol. 1994;102(4):334–340. doi: 10.1055/s-0029-1211300. [DOI] [PubMed] [Google Scholar]
  117. Milligan S. R., Khan O., Nash M. Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma. Gen Comp Endocrinol. 1998 Oct;112(1):89–95. doi: 10.1006/gcen.1998.7146. [DOI] [PubMed] [Google Scholar]
  118. Molteni A., Brizio-Molteni L., Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr. 1995 Mar;125(3 Suppl):751S–756S. doi: 10.1093/jn/125.3_Suppl.751S. [DOI] [PubMed] [Google Scholar]
  119. Morton M. S., Chan P. S., Cheng C., Blacklock N., Matos-Ferreira A., Abranches-Monteiro L., Correia R., Lloyd S., Griffiths K. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997 Jul 1;32(2):122–128. doi: 10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  120. Morton M. S., Chan P. S., Cheng C., Blacklock N., Matos-Ferreira A., Abranches-Monteiro L., Correia R., Lloyd S., Griffiths K. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997 Jul 1;32(2):122–128. doi: 10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  121. Morton M. S., Wilcox G., Wahlqvist M. L., Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol. 1994 Aug;142(2):251–259. doi: 10.1677/joe.0.1420251. [DOI] [PubMed] [Google Scholar]
  122. Morton M. S., Wilcox G., Wahlqvist M. L., Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol. 1994 Aug;142(2):251–259. doi: 10.1677/joe.0.1420251. [DOI] [PubMed] [Google Scholar]
  123. Mousavi Y., Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):615–619. doi: 10.1016/0960-0760(92)90393-w. [DOI] [PubMed] [Google Scholar]
  124. Murkies A. L., Lombard C., Strauss B. J., Wilcox G., Burger H. G., Morton M. S. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas. 1995 Apr;21(3):189–195. doi: 10.1016/0378-5122(95)00899-v. [DOI] [PubMed] [Google Scholar]
  125. Murrill W. B., Brown N. M., Zhang J. X., Manzolillo P. A., Barnes S., Lamartiniere C. A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 1996 Jul;17(7):1451–1457. doi: 10.1093/carcin/17.7.1451. [DOI] [PubMed] [Google Scholar]
  126. Mäkelä S., Poutanen M., Kostian M. L., Lehtimäki N., Strauss L., Santti R., Vihko R. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med. 1998 Mar;217(3):310–316. doi: 10.3181/00379727-217-44237. [DOI] [PubMed] [Google Scholar]
  127. Mäkelä S., Poutanen M., Lehtimäki J., Kostian M. L., Santti R., Vihko R. Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med. 1995 Jan;208(1):51–59. doi: 10.3181/00379727-208-43831. [DOI] [PubMed] [Google Scholar]
  128. Mäkelä S., Santti R., Salo L., McLachlan J. A. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect. 1995 Oct;103 (Suppl 7):123–127. doi: 10.1289/ehp.103-1518873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Nagata C., Kabuto M., Kurisu Y., Shimizu H. Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr Cancer. 1997;29(3):228–233. doi: 10.1080/01635589709514629. [DOI] [PubMed] [Google Scholar]
  130. Nagata C., Takatsuka N., Inaba S., Kawakami N., Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst. 1998 Dec 2;90(23):1830–1835. doi: 10.1093/jnci/90.23.1830. [DOI] [PubMed] [Google Scholar]
  131. Nagel S. C., vom Saal F. S., Welshons W. V. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med. 1998 Mar;217(3):300–309. doi: 10.3181/00379727-217-44236. [DOI] [PubMed] [Google Scholar]
  132. Naik H. R., Lehr J. E., Pienta K. J. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res. 1994 Nov-Dec;14(6B):2617–2619. [PubMed] [Google Scholar]
  133. Nestel P. J., Pomeroy S., Kay S., Komesaroff P., Behrsing J., Cameron J. D., West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999 Mar;84(3):895–898. doi: 10.1210/jcem.84.3.5561. [DOI] [PubMed] [Google Scholar]
  134. Nwannenna A. I., Madej A., Lundh T. J., Fredriksson G. Effects of oestrogenic silage on some clinical and endocrinological parameters in ovariectomized heifers. Acta Vet Scand. 1994;35(2):173–183. doi: 10.1186/BF03548345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Obst J. M., Seamark R. F. Plasma progesterone concentrations during the reproductive cycle of ewes grazing Yarloop clover. J Reprod Fertil. 1970 Apr;21(3):545–547. doi: 10.1530/jrf.0.0210545. [DOI] [PubMed] [Google Scholar]
  136. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun. 1988 Nov 30;157(1):183–189. doi: 10.1016/s0006-291x(88)80030-5. [DOI] [PubMed] [Google Scholar]
  137. Onoe Y., Miyaura C., Ohta H., Nozawa S., Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology. 1997 Oct;138(10):4509–4512. doi: 10.1210/endo.138.10.5575. [DOI] [PubMed] [Google Scholar]
  138. Osterlund M., Kuiper G. G., Gustafsson J. A., Hurd Y. L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res. 1998 Feb;54(1):175–180. doi: 10.1016/s0169-328x(97)00351-3. [DOI] [PubMed] [Google Scholar]
  139. Patisaul H. B., Whitten P. L., Young L. J. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol. Brain Res Mol Brain Res. 1999 Apr 6;67(1):165–171. doi: 10.1016/s0169-328x(99)00058-3. [DOI] [PubMed] [Google Scholar]
  140. Pelissero C., Lenczowski M. J., Chinzi D., Davail-Cuisset B., Sumpter J. P., Fostier A. Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol. 1996 Feb;57(3-4):215–223. doi: 10.1016/0960-0760(95)00261-8. [DOI] [PubMed] [Google Scholar]
  141. Petilli M., Fiorelli G., Benvenuti S., Frediani U., Gori F., Brandi M. L. Interactions between ipriflavone and the estrogen receptor. Calcif Tissue Int. 1995 Feb;56(2):160–165. doi: 10.1007/BF00296349. [DOI] [PubMed] [Google Scholar]
  142. Petrakis N. L., Barnes S., King E. B., Lowenstein J., Wiencke J., Lee M. M., Miike R., Kirk M., Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):785–794. [PubMed] [Google Scholar]
  143. Phipps W. R., Martini M. C., Lampe J. W., Slavin J. L., Kurzer M. S. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab. 1993 Nov;77(5):1215–1219. doi: 10.1210/jcem.77.5.8077314. [DOI] [PubMed] [Google Scholar]
  144. Piontek M., Hengels K. J., Porschen R., Strohmeyer G. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res. 1993 Nov-Dec;13(6A):2119–2123. [PubMed] [Google Scholar]
  145. Pollard M., Luckert P. H. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer. 1997;28(1):41–45. doi: 10.1080/01635589709514551. [DOI] [PubMed] [Google Scholar]
  146. Potter S. M., Baum J. A., Teng H., Stillman R. J., Shay N. F., Erdman J. W., Jr Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1375S–1379S. doi: 10.1093/ajcn/68.6.1375S. [DOI] [PubMed] [Google Scholar]
  147. Prins G. S., Marmer M., Woodham C., Chang W., Kuiper G., Gustafsson J. A., Birch L. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology. 1998 Mar;139(3):874–883. doi: 10.1210/endo.139.3.5827. [DOI] [PubMed] [Google Scholar]
  148. Register B., Bethel M. A., Thompson N., Walmer D., Blohm P., Ayyash L., Hughes C., Jr The effect of neonatal exposure to diethylstilbestrol, coumestrol, and beta-sitosterol on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Proc Soc Exp Biol Med. 1995 Jan;208(1):72–77. doi: 10.3181/00379727-208-43834. [DOI] [PubMed] [Google Scholar]
  149. Reinli K., Block G. Phytoestrogen content of foods--a compendium of literature values. Nutr Cancer. 1996;26(2):123–148. doi: 10.1080/01635589609514470. [DOI] [PubMed] [Google Scholar]
  150. Rondelli I., Acerbi D., Ventura P. Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure. Int J Clin Pharmacol Res. 1991;11(4):183–192. [PubMed] [Google Scholar]
  151. Rosenberg Zand R. S., Jenkins D. J., Diamandis E. P. Genistein: a potent natural antiandrogen. Clin Chem. 2000 Jun;46(6 Pt 1):887–888. [PubMed] [Google Scholar]
  152. Rosenblum E. R., Stauber R. E., Van Thiel D. H., Campbell I. M., Gavaler J. S. Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer. Alcohol Clin Exp Res. 1993 Dec;17(6):1207–1209. doi: 10.1111/j.1530-0277.1993.tb05230.x. [DOI] [PubMed] [Google Scholar]
  153. Rowland I. R., Wiseman H., Sanders T. A., Adlercreutz H., Bowey E. A. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36(1):27–32. doi: 10.1207/S15327914NC3601_5. [DOI] [PubMed] [Google Scholar]
  154. Rudel R. Predicting health effects of exposures to compounds with estrogenic activity: methodological issues. Environ Health Perspect. 1997 Apr;105 (Suppl 3):655–663. doi: 10.1289/ehp.97105s3655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Ruiz-Larrea M. B., Mohan A. R., Paganga G., Miller N. J., Bolwell G. P., Rice-Evans C. A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 1997 Jan;26(1):63–70. doi: 10.3109/10715769709097785. [DOI] [PubMed] [Google Scholar]
  156. Russo J., Russo I. H. Biological and molecular bases of mammary carcinogenesis. Lab Invest. 1987 Aug;57(2):112–137. [PubMed] [Google Scholar]
  157. Safe S. H. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect. 1995 Apr;103(4):346–351. doi: 10.1289/ehp.95103346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Santell R. C., Chang Y. C., Nair M. G., Helferich W. G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr. 1997 Feb;127(2):263–269. doi: 10.1093/jn/127.2.263. [DOI] [PubMed] [Google Scholar]
  159. Santell R. C., Kieu N., Helferich W. G. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr. 2000 Jul;130(7):1665–1669. doi: 10.1093/jn/130.7.1665. [DOI] [PubMed] [Google Scholar]
  160. Schoental R. Trichothecenes, zearalenone, and other carcinogenic metabolites of Fusarium and related microfungi. Adv Cancer Res. 1985;45:217–290. doi: 10.1016/s0065-230x(08)60270-5. [DOI] [PubMed] [Google Scholar]
  161. Setchell K. D., Gosselin S. J., Welsh M. B., Johnston J. O., Balistreri W. F., Kramer L. W., Dresser B. L., Tarr M. J. Dietary estrogens--a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology. 1987 Aug;93(2):225–233. doi: 10.1016/0016-5085(87)91006-7. [DOI] [PubMed] [Google Scholar]
  162. Setchell K. D., Welsh M. B., Lim C. K. High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr. 1987 Jan 16;386:315–323. doi: 10.1016/s0021-9673(01)94608-4. [DOI] [PubMed] [Google Scholar]
  163. Setchell K. D., Zimmer-Nechemias L., Cai J., Heubi J. E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 1997 Jul 5;350(9070):23–27. doi: 10.1016/S0140-6736(96)09480-9. [DOI] [PubMed] [Google Scholar]
  164. Setchell K. D., Zimmer-Nechemias L., Cai J., Heubi J. E. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1453S–1461S. doi: 10.1093/ajcn/68.6.1453S. [DOI] [PubMed] [Google Scholar]
  165. Sharma O. P., Adlercreutz H., Strandberg J. D., Zirkin B. R., Coffey D. S., Ewing L. L. Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol. 1992 Nov;43(6):557–564. doi: 10.1016/0960-0760(92)90244-d. [DOI] [PubMed] [Google Scholar]
  166. Sheehan D. M., Branham W. S., Medlock K. L., Shanmugasundaram E. R. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus. Teratology. 1984 Jun;29(3):383–392. doi: 10.1002/tera.1420290309. [DOI] [PubMed] [Google Scholar]
  167. Sheehan D. M. Herbal medicines, phytoestrogens and toxicity: risk:benefit considerations. Proc Soc Exp Biol Med. 1998 Mar;217(3):379–385. doi: 10.3181/00379727-217-44248. [DOI] [PubMed] [Google Scholar]
  168. Shughrue P. J., Lane M. V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol. 1997 Dec 1;388(4):507–525. doi: 10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  169. Shutt D. A., Cox R. I. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972 Feb;52(2):299–310. doi: 10.1677/joe.0.0520299. [DOI] [PubMed] [Google Scholar]
  170. Stancel G. M., Boettger-Tong H. L., Chiappetta C., Hyder S. M., Kirkland J. L., Murthy L., Loose-Mitchell D. S. Toxicity of endogenous and environmental estrogens: what is the role of elemental interactions? Environ Health Perspect. 1995 Oct;103 (Suppl 7):29–33. doi: 10.1289/ehp.95103s729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Stephens F. O. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust. 1997 Aug 4;167(3):138–140. doi: 10.5694/j.1326-5377.1997.tb138812.x. [DOI] [PubMed] [Google Scholar]
  172. Stone R. Environmental estrogens stir debate. Science. 1994 Jul 15;265(5170):308–310. doi: 10.1126/science.8023147. [DOI] [PubMed] [Google Scholar]
  173. Strauss L., Mäkelä S., Joshi S., Huhtaniemi I., Santti R. Genistein exerts estrogen-like effects in male mouse reproductive tract. Mol Cell Endocrinol. 1998 Sep 25;144(1-2):83–93. doi: 10.1016/s0303-7207(98)00152-x. [DOI] [PubMed] [Google Scholar]
  174. Tansey G., Hughes C. L., Jr, Cline J. M., Krümmer A., Walmer D. K., Schmoltzer S. Effects of dietary soybean estrogens on the reproductive tract in female rats. Proc Soc Exp Biol Med. 1998 Mar;217(3):340–344. doi: 10.3181/00379727-217-44242. [DOI] [PubMed] [Google Scholar]
  175. Tew B. Y., Xu X., Wang H. J., Murphy P. A., Hendrich S. A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. J Nutr. 1996 Apr;126(4):871–877. doi: 10.1093/jn/126.4.871. [DOI] [PubMed] [Google Scholar]
  176. Thompson L. U., Rickard S. E., Cheung F., Kenaschuk E. O., Obermeyer W. R. Variability in anticancer lignan levels in flaxseed. Nutr Cancer. 1997;27(1):26–30. doi: 10.1080/01635589709514497. [DOI] [PubMed] [Google Scholar]
  177. Thompson L. U., Robb P., Serraino M., Cheung F. Mammalian lignan production from various foods. Nutr Cancer. 1991;16(1):43–52. doi: 10.1080/01635589109514139. [DOI] [PubMed] [Google Scholar]
  178. Tobe H., Komiyama O., Komiyama Y., Maruyama H. B. Daidzein stimulation of bone resorption in pit formation assay. Biosci Biotechnol Biochem. 1997 Feb;61(2):370–371. doi: 10.1271/bbb.61.370. [DOI] [PubMed] [Google Scholar]
  179. Valente M., Bufalino L., Castiglione G. N., D'Angelo R., Mancuso A., Galoppi P., Zichella L. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int. 1994 May;54(5):377–380. doi: 10.1007/BF00305522. [DOI] [PubMed] [Google Scholar]
  180. Verma S. P., Salamone E., Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun. 1997 Apr 28;233(3):692–696. doi: 10.1006/bbrc.1997.6527. [DOI] [PubMed] [Google Scholar]
  181. Versantvoort C. H., Broxterman H. J., Lankelma J., Feller N., Pinedo H. M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol. 1994 Sep 15;48(6):1129–1136. doi: 10.1016/0006-2952(94)90149-x. [DOI] [PubMed] [Google Scholar]
  182. Wagner J. D., Cefalu W. T., Anthony M. S., Litwak K. N., Zhang L., Clarkson T. B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 1997 Jun;46(6):698–705. doi: 10.1016/s0026-0495(97)90016-0. [DOI] [PubMed] [Google Scholar]
  183. Walker B. E. Tumors of female offspring of mice exposed prenatally to diethylstilbestrol. J Natl Cancer Inst. 1984 Jul;73(1):133–140. [PubMed] [Google Scholar]
  184. Wang C., Mäkelä T., Hase T., Adlercreutz H., Kurzer M. S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):205–212. doi: 10.1016/0960-0760(94)90030-2. [DOI] [PubMed] [Google Scholar]
  185. Wang W. Radioimmunoassay determination of formononetin in murine plasma and mammary glandular tissue. Proc Soc Exp Biol Med. 1998 Mar;217(3):281–287. doi: 10.3181/00379727-217-44233. [DOI] [PubMed] [Google Scholar]
  186. Wang W., Tanaka Y., Han Z., Higuchi C. M. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer. 1995;23(2):131–140. doi: 10.1080/01635589509514369. [DOI] [PubMed] [Google Scholar]
  187. Wang W., Tanaka Y., Han Z., Higuchi C. M. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer. 1995;23(2):131–140. doi: 10.1080/01635589509514369. [DOI] [PubMed] [Google Scholar]
  188. Watanabe S., Yamaguchi M., Sobue T., Takahashi T., Miura T., Arai Y., Mazur W., Wähälä K., Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998 Oct;128(10):1710–1715. doi: 10.1093/jn/128.10.1710. [DOI] [PubMed] [Google Scholar]
  189. Weber K. S., Jacobson N. A., Setchell K. D., Lephart E. D. Brain aromatase and 5alpha-reductase, regulatory behaviors and testosterone levels in adult rats on phytoestrogen diets. Proc Soc Exp Biol Med. 1999 Jun;221(2):131–135. doi: 10.1046/j.1525-1373.1999.d01-66.x. [DOI] [PubMed] [Google Scholar]
  190. Wei H., Bowen R., Cai Q., Barnes S., Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med. 1995 Jan;208(1):124–130. doi: 10.3181/00379727-208-43844. [DOI] [PubMed] [Google Scholar]
  191. Welshons W. V., Rottinghaus G. E., Nonneman D. J., Dolan-Timpe M., Ross P. F. A sensitive bioassay for detection of dietary estrogens in animal feeds. J Vet Diagn Invest. 1990 Oct;2(4):268–273. doi: 10.1177/104063879000200403. [DOI] [PubMed] [Google Scholar]
  192. Whitten P. L., Lewis C., Naftolin F. A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol Reprod. 1993 Nov;49(5):1117–1121. doi: 10.1095/biolreprod49.5.1117. [DOI] [PubMed] [Google Scholar]
  193. Whitten P. L., Lewis C., Russell E., Naftolin F. Phytoestrogen influences on the development of behavior and gonadotropin function. Proc Soc Exp Biol Med. 1995 Jan;208(1):82–86. doi: 10.3181/00379727-208-43836. [DOI] [PubMed] [Google Scholar]
  194. Whitten P. L., Russell E., Naftolin F. Effects of a normal, human-concentration, phytoestrogen diet on rat uterine growth. Steroids. 1992 Mar;57(3):98–106. doi: 10.1016/0039-128x(92)90066-i. [DOI] [PubMed] [Google Scholar]
  195. Wilcox G., Wahlqvist M. L., Burger H. G., Medley G. Oestrogenic effects of plant foods in postmenopausal women. BMJ. 1990 Oct 20;301(6757):905–906. doi: 10.1136/bmj.301.6757.905-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Winter J. S., Hughes I. A., Reyes F. I., Faiman C. Pituitary-gonadal relations in infancy: 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab. 1976 Apr;42(4):679–686. doi: 10.1210/jcem-42-4-679. [DOI] [PubMed] [Google Scholar]
  197. Wiseman H., O'Reilly J. The cardioprotective antioxidant activity of dietary phytoestrogens compared to oestrogen. Biochem Soc Trans. 1997 Feb;25(1):107S–107S. doi: 10.1042/bst025107s. [DOI] [PubMed] [Google Scholar]
  198. Xu X., Duncan A. M., Merz B. E., Kurzer M. S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1101–1108. [PubMed] [Google Scholar]
  199. Xu X., Harris K. S., Wang H. J., Murphy P. A., Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr. 1995 Sep;125(9):2307–2315. doi: 10.1093/jn/125.9.2307. [DOI] [PubMed] [Google Scholar]
  200. Xu X., Wang H. J., Murphy P. A., Cook L., Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr. 1994 Jun;124(6):825–832. doi: 10.1093/jn/124.6.825. [DOI] [PubMed] [Google Scholar]
  201. Yamazaki I. Effect of ipriflavone on the response of uterus and thyroid to estrogen. Life Sci. 1986 Feb 24;38(8):757–764. doi: 10.1016/0024-3205(86)90591-6. [DOI] [PubMed] [Google Scholar]
  202. Yoshida K., Tsukamoto T., Torii H., Doi T., Naeshiro I., Shibata K., Uemura I., Tanayama S. Disposition of ipriflavone (TC-80) in rats and dogs. Radioisotopes. 1985 Nov;34(11):618–623. doi: 10.3769/radioisotopes.34.11_618. [DOI] [PubMed] [Google Scholar]
  203. Zacharewski T. Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays. Environ Health Perspect. 1998 Apr;106 (Suppl 2):577–582. doi: 10.1289/ehp.98106577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Zava D. T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27(1):31–40. doi: 10.1080/01635589709514498. [DOI] [PubMed] [Google Scholar]
  205. Zava D. T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27(1):31–40. doi: 10.1080/01635589709514498. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES